Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05876676
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-30
First Post:
2023-05-17
Brief Title:
RDC Biomarker Study
Sponsor:
Organization:
Royal Marsden NHS Foundation Trust
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
12 Months
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Saliva - polygenic risk score - all patientsall sites Bloods - methylation - all patientsall sites Bloods - Exosome - 300 patientsLondon sites only Bloods - Immunophenotype - 300 patientsLondon sites only Breath Condensate - Breathanomics - 300 patients5 London sites
Enrollment Count:
1000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 95698 |
Who Masked List: